Pneumococcal microbiology and immunity

Pediatric Annals

Volumn 31, Issue 4, 2002, Pages 233-240

  Gray, Barry M ^a  

^a Gibbs Cancer Center and Research Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADHESIN; BACTERIAL POLYSACCHARIDE; BINDING PROTEIN; CELL SURFACE PROTEIN; PNEUMOLYSIN; PROTEINASE; SIALIDASE; TEICHOIC ACID; VIRULENCE FACTOR;

ANTIBODY RESPONSE; BACTERIAL CELL WALL; BACTERIAL COLONIZATION; BACTERIAL MEMBRANE; BACTERIAL VIRULENCE; BACTERICIDAL ACTIVITY; CELL SURFACE; IMMUNITY; OPSONIZATION; REVIEW; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE;

EID: 0036220248     PISSN: 00904481     EISSN: None     Source Type: Journal    
DOI: 10.3928/0090-4481-20020401-06     Document Type: Review

References (46)

1. Pneumococcus: The first one hundred years
2. Mechanisms of host defense against infection with Streptococcus pneumoniae
3. A brief history of the pneumococcus in biomedical research: A panoply of scientific discovery
4. Pneumococcal virulence factors and host immune responses to them
5. Streptococcus pneumoniae infections
6. Complete genome sequence of a virulent isolate of Streptococcus pneumoniae
7. Use of a whole genome approach to identify vaccine molecules affording protection against Streptococcus pneumoniae infection
8. Recombinational exchanges at the capsular polysaccharide biosynthetic locus lead to frequent serotype changes among natural isolates of Streptococcus pneumoniae
9. Relationship between phase variation in colony morphology, intrastrain variation in cell wall physiology, and nasopharyngeal colonization by Streptococcus pneumoniae
10. Antiphosphocholine antibodies found in normal mouse serum are protective against intravenous infection with type 3 Streptococcus pneumoniae
11. Epidemiological studies of Streptococcus pneumoniae in infants: Development of antibody to phosphocholine
12. Opsonization and antibodies to capsular and cell wall polysaccharides of Streptococcus pneumoniae
13. Immunization of humans with recombinant pneumococcal surface protein A (rPspA) elicits antibodies that passively protect mice from fatal infection with Streptococcus pneumoniae bearing heterologous PspA
14. Protection against Streptococcus pneumoniae elicited by immunization with pneumolysin and CbpA
15. Intranasal immunization of mice with a mixture of the pneumococcal proteins PsaA and PspA is highly protective against nasopharyngeal carriage of Streptococcus pneumoniae
16. The role of pneumolysin and autolysin in the pathology of pneumonia and septicemia in mice infected with a type 2 pneumococcus
17. Molecular analysis of the pathogenicity of Streptococcus pneumoniae: The role of pneumococcal proteins
18. Evaluation of the virulence of a Streptococcus pneumoniae neuraminidase-deficient mutant in nasopharyngeal colonization and development of otitis media in the chinchilla model
19. Is pneumococcal hemolytic-uremic syndrome a new disease?
20. Two structural transitions in membrane pore formation by pneumolysin, the pore-forming toxin of Streptococcus pneumoniae
21. Induction of necrosis and apoptosis of neutrophil granulocytes by Streptococcus pneumoniae
22. The cell wall mediates pneumococcal attachment to and cytopathology in human endothelial cells
23. Neuroprotection by a caspase inhibitor in acute bacterial meningitis
24. Relative roles of pneumolysin and hydrogen peroxide from Streptococcus pneumoniae in inhibition of ependymal ciliary beat frequency
25. Protection against bacteremic pneumococcal infection by antibody to pneumolysin
26. Epidemiologic studies of Streptococcus pneumoniae in infants: Acquisition, carriage, and infection during the first 24 months of life
27. A folding variant of alpha-lactalbumin with bactericidal activity against Streptococcus pneumoniae
28. Inhibition of attachment of Streptococcus pneumoniae and Haemophilus influenzae by human milk and receptor oligosaccharides
29. Xylitol in preventing acute otitis media
30. Toll-like receptors and innate immunity
31. Cutting edge: Recognition of gram-positive bacterial cell wall components by the innate immune system occurs via Toll-like receptor 2
32. Pneumolysin is the main inducer of cytotoxicity to brain microvascular endothelial cells caused by Streptococcus pneumoniae
33. Pneumococcal trafficking across the blood-brain barrier: Molecular analysis of a novel bidirectional pathway
34. Streptococcus pneumoniae causes experimental meningitis following intranasal and otitis media infections via a nonhematogenous route
35. Antibody to capsular polysaccharide of Streptococcus pneumoniae at the time of hospital admission for pneumococcal pneumonia
36. Emergence of antibody to capsular polysaccharides of Streptococcus pneumoniae during outbreaks of pneumonia: Association with nasopharyngeal colonization
37. Pneumococcal vaccines: Present and future
38. Immunity to cross-reactive serotypes induced by pneumococcal conjugate vaccines in infants
39. Efficacy of a pneumococcal conjugate vaccine against acute otitis media
40. Natural development of antibodies to pneumococcal surface protein A, pneumococcal surface adhesin A, and pneumolysin in relation to pneumococcal carriage and acute otitis media
41. Pneumococcal carriage and otitis media induce salivary antibodies to pneumococcal surface adhesin A, pneumolysin, and pneumococcal surface protein A in children
42. Intranasal immunization of mice with PspA (pneumococcal surface protein A) can prevent intranasal carriage, pulmonary infection, and sepsis with Streptococcus pneumoniae
43. Antibody response to the pneumococcal proteins pneumococcal surface adhesin A and pneumolysin in children with acute otitis media
44. Nasopharyngeal antibodies to pneumococcal pneumolysin in children with acute otitis media
45. Serum and salivary anti-capsular antibodies in infants and children immunized with the heptavalent pneumococcal conjugate vaccine
46. Immunogenicity and impact on nasopharyngeal carriage of a nonvalent pneumococcal conjugate vaccine